by admin | 8th September 2022 | News, Uncategorized
New York and London– September 8, 2022 – OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO;), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, today announces that an interview with... by admin | 7th September 2022 | News, Uncategorized
The board of directors of OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a bio-pharmaceutical company focused on developing an innovative approach to dry eye care and ocular pain, is pleased to announce that at the Annual General Meeting (“AGM”) of the... by admin | 20th March 2022 | Uncategorized
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!